AI assistant
Sending…
Lineage Cell Therapeutics Inc. — Proxy Solicitation & Information Statement 2025
Jun 23, 2025
6895_rns_2025-06-23_78a0aa43-0b42-4e23-9a00-352d5d5205e6.htm
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
ANNUAL MEETING OF SHAREHOLDERS - PROXY false
| ������' �� ��������� ���� | 2 380 |
| .LINEAGE CELL THERAPEUTICS, INC | |
| Corporation no: 876343 | 10834 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 23/06/2025 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2025-02-044593 | Time of broadcast: 18:45 18:45 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onANNUAL MEETING OF SHAREHOLDERS - PROXY
FORM_DEF_14A_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 06/08/2024 |
| Address: HARBOR BAY PARKWAY 1301 , ALAMEDA 94502 CALIFORNIA , U.S.A Tel: 5105213390 , Fax: 5105213389 | |
| E-mail address: [email protected] Company site: biotimeinc.com | |
| Previous names of reporting entity: .BIOTIME, INC | |
| Name of the Signatory: Gerzi SHNEOR Ilan Position of Signatory in the reporting corporation: Legal Adviser Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ | |
| Address: Derech Menachem Begin 121 , Tel Aviv 6701203 Telephone: 03-3039000 Facsimile: E-mail: [email protected] 1 | |
| U.S.A |
More from Lineage Cell Therapeutics Inc.
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Report Publication Announcement
2026
May 13
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Report Publication Announcement
2026
May 5
Earnings Release
2026
May 5
Investor Presentation
2026
May 4